Product
evinacumab
Aliases
REGN1500
Name
Evkeeza
INN Name
evinacumab
FDA Approved
Yes
3 clinical trials
1 organization
2 indications
1 document
Indication
Homozygous Familial HypercholesterolemiaIndication
HypertriglyceridemiaClinical trial
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaStatus: Completed, Estimated PCD: 2023-04-13
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Evinacumab in Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute PancreatitisStatus: Terminated, Estimated PCD: 2023-02-15
Clinical trial
A Phase 2, Randomized, Placebo-Controlled Study of Safety and Efficacy, Following Repeat-Dose Administration of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute PancreatitisStatus: Completed, Estimated PCD: 2019-12-17
Document
DailyMed Label: EvkeezaOrganization
Regeneron Pharmaceuticals, Inc.